Severity Index of Neonatal Septicemia Using Score for Neonatal Acute Physiology (SNAP) II
- Conditions
- Neonatal SEPSIS
- Registration Number
- NCT03746743
- Lead Sponsor
- Ahmed Mahmoud Ali Ali Youssef
- Brief Summary
To determine the effect of Score for Neonatal Acute Physiology II as a Predictor of Mortality and Organ Dysfunction in Neonates with Septicemia in the Neonatal Intensive Care Units at CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and at ELGALAA Children's MILITARY HOSPITAL.
- Detailed Description
This study will be conducted at the Neonatal intensive care Units at CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and at ELGALAA Children's MILITARY HOSPITAL.
Population of study \& disease condition:
Neonates with septicemia admitted to NICUs in CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and in ELGALAA Children's MILITARY HOSPITAL.
Inclusion criteria:
1. Type of patient: Neonates with septicemia.
2. Age of patient: From 0-28 Days.
3. Sex: males and females.
Exclusion criteria:
1. Neonates with proved inborn error of metabolism.
2. Neonates with multiple congenital anomalies.
3. Neonates with severe birth asphyxia (APGAR score \<4 at 5 minutes).
Methodology in details:
We will have 2 groups, each of them 50 neonates with septicemia. One group of premature neonates (32-36 weeks), the other group of full term neonates (\>37 weeks).
All included Patients will be subjected to the following:
1. Full history with emphasis of relevant data as follows:
Date of birth, gestational age (AGA or SGA), gender, day of sepsis onset.
2. Clinical assessment:
Full systems examination.
3. Diagnosis of sepsis:
* By abnormal Total leucocytic count or I/T ratio or CRP with clinical Suggestion (poor feeding, hepatomegaly, apnea, tachypnea, lethargy, ...).
* Confirm diagnosis by blood culture.
Sepsis will be considered severe if the neonate has sepsis plus one of the following: 1) cardiovascular organ dysfunction (hypotension or need for vasoactive drug) 2) 2 of the following (metabolic acidosis, increase lactic acid, oliguria, Prolonged capillary refill time) 3) Organ dysfunction (respiratory, renal, neurologic, hematologic).
4. SNAP II score:
For all neonates included in the study and its data collection within 24 hours from onset of sepsis, in the form of:
* Lowest mean blood pressure.
* Worst ratio of pao2/fio2
* Lowest temperature.
* Lowest serum PH.
* Occurrence of multiple seizures.
* Urine output\<1 ml/kg/hour.
5. Follow up:
Follow up all neonates included in the study for 14 days: for morbidity and mortality.
6. Diagnosis of organ dysfunction:
Respiratory: by CXR and clinical examination. CVS: by blood pressure, capillary refill time, shock and need for inotropes. Renal: by urine output, kidney function tests. Hematology: by picture of DIC or pancytopenia. Neurology: by seizures, dilated fixed pupil.
Possible Risk:
None.
Primary outcomes:
Using Score for Neonatal Acute Physiology II as a Predictor of Mortality and Organ Dysfunction in Neonates with Septicemia.
Secondary outcomes:
Early anticipation of clinical manifestations of sepsis which will correlate most with poor outcome.
Sample size:
100 Neonates with septicemia admitted to NICUs in CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and in ELGALAA Children's MILITARY HOSPITAL.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Type of patient: Neonates with septicemia.
- Age of patient: From 0-28 Days.
- Sex: males and females.
- Neonates with proved inborn error of metabolism.
- Neonates with multiple congenital anomalies.
- Neonates with severe birth asphyxia (APGAR score <4 at 5 minutes).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Using Score for Neonatal Acute Physiology II as a Predictor of Mortality and Organ Dysfunction in Neonates with Septicemia. through study completion, an average of 1 year
- Secondary Outcome Measures
Name Time Method Early anticipation of clinical manifestations of sepsis which will correlate most with poor outcome. through study completion, an average of 1 year
Trial Locations
- Locations (1)
Faculty Of medicine Cairo University
🇪🇬Giza, Egypt
Faculty Of medicine Cairo University🇪🇬Giza, Egypt